Thymoma is an uncommon epithelial tumour originating from the thymus gland, having an incidence of 0.13 ... frequently present with paraneoplastic diseases, especially myasthenia gravis, whereas ...

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed. Finding similar frequencies of ...

Excitingly, in myasthenia [gravis], we have entered the advanced therapy era with the approval of the complement inhibitors starting in 2017, and now, more recently, the FcRn [neonatal Fc receptor ...

Background: The ability to distinguish between a normal thymus, thymic hyperplasia, and thymoma should aid in clinical management and decision making for patients with myasthenia gravis (MG). We ...

“Our discovery—the regulatory T cell recirculation back to the thymus—promotes repair through ... a novel pathway to regeneration in the gland,” said lead author Andri Lemarquis, MD ...

Between the lungs and in front of the heart sits a small gland called the thymus that wields incredible power over human health by producing T cells, key components of our immune system.

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...

The researchers were able to show that in the thymus gland of humans and mice not only the epithelial cells but also B cells express and present AQP4 to the T cell precursors. If the B cells were ...